CI-MPSC@EC2602A(19075.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
CI-MPSC@EC2602A
19075.HK
News
View More

HK-listed Microport set to climb most since September on expected swing to annual profit

Shares of Microport Scientific Corp rose 13.6% to HK$14.16, marking their highest level since October 10. The stock is set for its largest one-day percentage increase since September 1, continuing a four-day gain streak. Microport anticipates a return to profitability in 2025, projecting a net profit of at least $20 million, a significant recovery from a $268 million loss in 2024. This turnaround is attributed to increased product sales overseas and reduced operating expenses, enhancing gross profit margins. Year-to-date, the stock is up 20.1%, compared to a 4.2% rise in the Hang Seng Index.

Reuters·
HK
02252
-1.26%
HK
02160
-7.06%
HK
02172
-2.49%
Reuters·
HK
02252
-1.26%
HK
02160
-7.06%
HK
02172
-2.49%

MicroPort rose nearly 8% after issuing a profit warning, expecting to turn a profit last year

MICROPORT opened high today at 6.34%, reaching a maximum of 13.95 yuan. It is currently reported at 13.45 yuan, up 7.95%, with a trading volume of 15.7865 million shares, involving a capital of 213 million yuan. The company recently issued a profit warning, expecting to turn a profit in the fiscal year 2025, with a net profit of no less than 20 million USD, compared to a net loss of 268 million USD in the previous year

AASTOCKS·
SH
688351
+1.39%
HK
02160
-7.06%
HK
02252
-1.26%
AASTOCKS·
SH
688351
+1.39%
HK
02160
-7.06%
HK
02252
-1.26%

MicroPort Scientific Flags Return to Profit on Overseas Growth and Cost Cuts

MicroPort Scientific (HK:0853) has announced a positive profit alert, expecting a net profit of at least US$20 million for the year ending December 31, 2025, a turnaround from a net loss of approximately US$268 million the previous year. This improvement is driven by 70% revenue growth in its overseas business, enhanced gross margins from cost optimization, reduced operating expenses, and gains from subsidiary disposals. The stock currently holds a Hold rating with a price target of HK$11.00, reflecting a significant operational and financial recovery ahead of full results due by March 2026.

Tip Ranks·
HK
00853
-1.92%
Tip Ranks·
HK
00853
-1.92%

MicroPort Scientific (HKG:853) delivers shareholders splendid 119% return over 1 year, surging 8.6% in the last week alone

MicroPort Scientific Corporation (HKG:853) has delivered a remarkable 119% return to shareholders over the past year, despite a recent 17% drop in share price in the last quarter. The stock surged 8.6% in the past week, adding HK$1.8 billion to its market cap. However, the company reported a 0.7% decline in revenue, raising questions about its long-term growth potential. Insider buying in the past year is a positive sign, but future earnings will be crucial for sustaining shareholder returns. Overall, the short-term gains contrast with a long-term TSR loss of 12% per year over five years.

Simplywall·
HK
00853
-1.92%
Simplywall·
HK
00853
-1.92%

BD transactions and policy dividends resonate, the pharmaceutical sector will have a strong rebound in 2025

The overseas expansion of innovative drugs and BD transactions have driven the explosive growth of stock prices in the pharmaceutical sector. By 2025, net purchases from southbound funds are expected to reach HKD 1.4 trillion, with the Hong Kong Stock Exchange Healthcare Index increasing by 76% this year. Structural differentiation is evident in the biopharmaceutical sector, with companies possessing First-in-Class or Best-in-Class R&D pipelines being more favored. The medical devices and supplies sector has performed well, with representative companies such as WEIGAO GROUP and MICROPORT seeing increases of 38% and 76% respectively this year

BambooWorks·
HK
01066
-4.94%
HK
00853
-1.92%
BambooWorks·
HK
01066
-4.94%
HK
00853
-1.92%
© 2026 Longbridge｜Disclaimer